These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 35928505)
1. Adjunctive Recombinant Human Plasma Gelsolin for Severe Coronavirus Disease 2019 Pneumonia. DiNubile MJ; Parra S; Salomó AC; Levinson SL Open Forum Infect Dis; 2022 Aug; 9(8):ofac357. PubMed ID: 35928505 [TBL] [Abstract][Full Text] [Related]
2. Safety and Pharmacokinetics of Recombinant Human Plasma Gelsolin in Patients Hospitalized for Nonsevere Community-Acquired Pneumonia. Tannous A; Levinson SL; Bolognese J; Opal SM; DiNubile MJ Antimicrob Agents Chemother; 2020 Sep; 64(10):. PubMed ID: 32690640 [TBL] [Abstract][Full Text] [Related]
3. Recombinant Human Plasma Gelsolin Improves Survival and Attenuates Lung Injury in a Murine Model of Multidrug-Resistant DiNubile MJ; Levinson SL; Stossel TP; Lawrenz MB; Warawa JM Open Forum Infect Dis; 2020 Aug; 7(8):ofaa236. PubMed ID: 32766380 [TBL] [Abstract][Full Text] [Related]
4. Recombinant human plasma gelsolin (rhu-pGSN) in a patient hospitalized with critical COVID-19 pneumonia. Catteeuw JV; DiNubile MJ Clin Infect Pract; 2021 Nov; 12():100088. PubMed ID: 34396087 [TBL] [Abstract][Full Text] [Related]
5. Delayed administration of recombinant plasma gelsolin improves survival in a murine model of severe influenza. Yang Z; Bedugnis A; Levinson S; DiNubile M; Stossel T; Lu Q; Kobzik L F1000Res; 2019; 8():1860. PubMed ID: 31824672 [No Abstract] [Full Text] [Related]
6. Delayed Administration of Recombinant Plasma Gelsolin Improves Survival in a Murine Model of Penicillin-Susceptible and Penicillin-Resistant Pneumococcal Pneumonia. Yang Z; Bedugnis A; Levinson S; Dinubile M; Stossel T; Lu Q; Kobzik L J Infect Dis; 2019 Sep; 220(9):1498-1502. PubMed ID: 31287867 [TBL] [Abstract][Full Text] [Related]
7. Plasma gelsolin improves lung host defense against pneumonia by enhancing macrophage NOS3 function. Yang Z; Chiou TT; Stossel TP; Kobzik L Am J Physiol Lung Cell Mol Physiol; 2015 Jul; 309(1):L11-6. PubMed ID: 25957291 [TBL] [Abstract][Full Text] [Related]
8. Plasma gelsolin modulates the production and fate of IL-1β-containing microparticles following high-pressure exposure and decompression. Bhopale VM; Ruhela D; Brett KD; Nugent NZ; Fraser NK; Levinson SL; DiNubile MJ; Thom SR J Appl Physiol (1985); 2021 May; 130(5):1604-1613. PubMed ID: 33764168 [TBL] [Abstract][Full Text] [Related]
9. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
10. Low Admission Plasma Gelsolin Concentrations Identify Community-acquired Pneumonia Patients at High Risk for Severe Outcomes. Self WH; Wunderink RG; DiNubile MJ; Stossel TP; Levinson SL; Williams DJ; Anderson EJ; Bramley AM; Jain S; Edwards KM; Grijalva CG Clin Infect Dis; 2019 Sep; 69(7):1218-1225. PubMed ID: 30561561 [TBL] [Abstract][Full Text] [Related]
11. [Plasma gelsolin level and its relationship with the prognosis of patients with severe burns]. Huang LF; Yao YM; Dong N; He LX; Zhang QH; Yu Y; Sheng ZY Zhonghua Shao Shang Za Zhi; 2013 Apr; 29(2):148-51. PubMed ID: 23985203 [TBL] [Abstract][Full Text] [Related]
12. Plasma gelsolin and circulating actin correlate with hemodialysis mortality. Lee PS; Sampath K; Karumanchi SA; Tamez H; Bhan I; Isakova T; Gutierrez OM; Wolf M; Chang Y; Stossel TP; Thadhani R J Am Soc Nephrol; 2009 May; 20(5):1140-8. PubMed ID: 19389844 [TBL] [Abstract][Full Text] [Related]
14. Persistent depletion of plasma gelsolin (pGSN) after exposure of mice to heavy silicon ions. Rithidech KN; Reungpatthanaphong P; Tungjai M; Jangiam W; Honikel L; Whorton EB Life Sci Space Res (Amst); 2018 May; 17():83-90. PubMed ID: 29753417 [TBL] [Abstract][Full Text] [Related]
16. [Prognostic significance of plasma gelsolin in severe burn patients with sepsis]. Huang L; Yao Y; Dong N; He L; Zhang Q; Yu Y; Sheng Z Zhonghua Shao Shang Za Zhi; 2016 Feb; 32(2):77-81. PubMed ID: 26902273 [TBL] [Abstract][Full Text] [Related]
17. Plasma Gelsolin Level in HIV-1-Infected Patients: An Indicator of Disease Severity. Sinha KK; Peddada N; Jha PK; Mishra A; Pandey K; Das VN; Ashish ; Das P AIDS Res Hum Retroviruses; 2017 Mar; 33(3):254-260. PubMed ID: 27700141 [TBL] [Abstract][Full Text] [Related]
18. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial. Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777 [TBL] [Abstract][Full Text] [Related]
19. Plasma Gelsolin and Its Association with Mortality and Hospitalization in Chronic Hemodialysis Patients. Flores Gama C; Rosales LM; Ouellet G; Dou Y; Thijssen S; Usvyat L; Zhang H; Kuntsevich V; Levin NW; Kotanko P Blood Purif; 2017; 43(1-3):210-217. PubMed ID: 28114138 [TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial. Akova M; Unal S Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]